Updated
Inovio PharmaceuticalsINO · Healthcare
$1.22-15.86%
Market cap$100M
IndustryBiotechnology
Inovio Pharmaceuticals (INO) Superinvestor holders
3 of the superinvestors we track hold Inovio Pharmaceuticals (INO) in their latest 13F filings, $3M in total.
Summary
The largest holder is David Shaw (D. E. Shaw & Co.), with $1M, 0.0% of the portfolio.
In their latest quarter: 1 added, 2 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| David Shaw D. E. Shaw & Co. |
Trimmed | 1,351,656 | $1M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 1,239,778 | $1M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 361,339 | $397,473 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 3 |
| Q1 2026 | 4 |
| Q4 2025 | 4 |
| Q3 2025 | 3 |
| Q2 2025 | 3 |
| Q1 2025 | 3 |
| Q4 2024 | 2 |
| Q3 2024 | 2 |
Questions about Inovio Pharmaceuticals
Which superinvestors own Inovio Pharmaceuticals?
3 of the superinvestors we track hold Inovio Pharmaceuticals (INO) in their latest 13F filings, $3M in total. David Shaw, Two Sigma, Jim Simons.
Who is the largest superinvestor holder of INO?
The largest holder is David Shaw (D. E. Shaw & Co.), with $1M, 0.0% of the portfolio.
From Inovio Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.